The WPI BioProcess Center is uniquely positioned within the WPI Life Sciences and Bioengineering complex, promoting collaboration among faculty, graduate students, and industry partners.
Examples of current and past interdisciplinary research include:
Dyax Corp., headquartered in Cambridge, MA, outsourced fermentation process work at the WPI BioProcess Center.
The research team used a high yield production process that led to innovation in the biopharmaceutical industry. Dyax Corp. received approval from the U.S. Food and Drug Administration for KALBITOR® (ecallantide), a potent, selective, and reversible plasma kallikrein inhibitor, for the treatment of hereditary angioedema (HAE).
“Dyax and the WPI BioProcess facility have worked together on projects for over ten years. Throughout this time, the WPI BioProcess team has proved to be highly competent, effective, and responsive to project needs, costs, and timelines.”
-- Arthur C. Ley, Ph.D.
EdeniQ, a California-based company, is working to commercialize next-generation biofuels.
EdeniQ has licensed technology from the WPI BioProcess Center for the development of cellulosic ethanol, a liquid fuel derived not from food crops, but from agricultural waste and other sources of environmentally-sound biomass.
“The research from WPI is integral to our ongoing development of a scalable, cost-effective cellulosic solution.”
-- Larry Gross
Polymer Enhanced Diafiltration (PEDF) using PGA: United States Patent 6,533,938
This innovative application of a charged biopolymer, polyglutamic acid, achieves enhanced and efficient removal of heavy metal ions from water at high volume and/or low metal ion concentration.
For more information about research partnerships, visit Research at WPI.Maintained by email@example.com
Last modified: June 17, 2011 13:16:45